NASDAQ:BSTC
Delisted
BioSpecifics Technologies Corp Stock News
$88.53
+0 (+0%)
At Close: May 27, 2022
Is BioSpecifics Technologies (BSTC) Outperforming Other Medical Stocks This Year?
12:00am, Friday, 10'th Apr 2020BioSpecifics names Joseph Truitt as interim CEO BSTC
12:30pm, Thursday, 09'th Apr 2020
BioSpecifics names Joseph Truitt as interim CEO BSTC
BioSpecifics Reports CEO J. Kevin Buchi Leaving Co.; Names Joseph Truitt Interim CEO
12:09pm, Thursday, 09'th Apr 2020BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors
12:05pm, Thursday, 09'th Apr 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product markete
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
12:00pm, Thursday, 09'th Apr 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product markete
Synthetic Opioids Market Size & Share by Sales Revenue, Demands, Growth Factors, Types, Applications and Emerging Trends by 2026
03:51am, Thursday, 09'th Apr 2020
Apr 08, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry" The "Synthetic Opioids Market" research...
Man Group plc Raises Stake in BioSpecifics Technologies Corp. (NASDAQ:BSTC)
10:10am, Wednesday, 08'th Apr 2020
Man Group plc increased its holdings in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission.
BioSpecifics (BSTC) Upgraded to Strong Buy: Here's Why
04:00pm, Tuesday, 07'th Apr 2020
BioSpecifics (BSTC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BioSpecifics (BSTC) Upgraded to Strong Buy: Here's Why
04:00pm, Tuesday, 07'th Apr 2020
BioSpecifics (BSTC) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why BioSpecifics Technologies Corp.’s (NASDAQ:BSTC) High P/E Ratio Isn’t Necessarily A Bad Thing
12:59pm, Tuesday, 07'th Apr 2020
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
Goldman Sachs Group Inc. Decreases Holdings in BioSpecifics Technologies Corp. (NASDAQ:BSTC)
10:28am, Tuesday, 07'th Apr 2020
Goldman Sachs Group Inc. cut its holdings in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 9.8% in the 4th quarter, according to the company in its most recent filing with the Securities
First Republic Investment Management Inc. Sells 238 Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC)
01:22pm, Friday, 03'rd Apr 2020
First Republic Investment Management Inc. reduced its holdings in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 5.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned
Yes, You Can Time the Market. Find out How - April 02, 2020
02:22pm, Thursday, 02'nd Apr 2020
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Yes, You Can Time the Market. Find out How - April 02, 2020
02:22pm, Thursday, 02'nd Apr 2020
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
